NO20034527L - 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser - Google Patents

3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser

Info

Publication number
NO20034527L
NO20034527L NO20034527A NO20034527A NO20034527L NO 20034527 L NO20034527 L NO 20034527L NO 20034527 A NO20034527 A NO 20034527A NO 20034527 A NO20034527 A NO 20034527A NO 20034527 L NO20034527 L NO 20034527L
Authority
NO
Norway
Prior art keywords
diazabicyclo
formulations
antiarrhythmic compounds
antiarrhythmic
compounds
Prior art date
Application number
NO20034527A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034527D0 (no
Inventor
Neil Barnwell
Annika Bjoere
Lal Cheema
David Clading-Boel
Adam Herring
Karin Loevqvist
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20034527D0 publication Critical patent/NO20034527D0/no
Publication of NO20034527L publication Critical patent/NO20034527L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20034527A 2001-04-12 2003-10-09 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser NO20034527L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101327A SE0101327D0 (sv) 2001-04-12 2001-04-12 New crystalline forms
PCT/SE2002/000725 WO2002083688A1 (en) 2001-04-12 2002-04-12 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds

Publications (2)

Publication Number Publication Date
NO20034527D0 NO20034527D0 (no) 2003-10-09
NO20034527L true NO20034527L (no) 2003-12-10

Family

ID=20283783

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034527A NO20034527L (no) 2001-04-12 2003-10-09 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser

Country Status (30)

Country Link
US (1) US7217708B2 (de)
EP (2) EP1550663A1 (de)
JP (1) JP2004525970A (de)
KR (1) KR20030087078A (de)
CN (1) CN1269823C (de)
AR (1) AR035452A1 (de)
AT (1) ATE323095T1 (de)
BR (1) BR0208829A (de)
CA (1) CA2443470A1 (de)
CZ (1) CZ20032760A3 (de)
DE (1) DE60210598T2 (de)
DK (1) DK1389213T3 (de)
EE (1) EE200300504A (de)
ES (1) ES2261721T3 (de)
HK (1) HK1061026A1 (de)
HU (1) HUP0303487A3 (de)
IL (1) IL158250A0 (de)
IS (1) IS6980A (de)
MX (1) MXPA03009206A (de)
NO (1) NO20034527L (de)
NZ (1) NZ528560A (de)
PL (1) PL367179A1 (de)
PT (1) PT1389213E (de)
RU (1) RU2286993C2 (de)
SE (1) SE0101327D0 (de)
SK (1) SK12572003A3 (de)
TW (1) TWI237025B (de)
UA (1) UA74629C2 (de)
WO (1) WO2002083688A1 (de)
ZA (1) ZA200307759B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI259836B (en) * 2001-04-12 2006-08-11 Astrazeneca Ab Modified release formulation suitable for antiarrhythmic compounds
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401539D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
AR057064A1 (es) * 2005-06-13 2007-11-14 Astrazeneca Ab Compuestos para el tratamiento de arritmias cardiacas, formulacion farmaceutica y preparacion del compuesto
EP1915380A4 (de) * 2005-06-20 2010-03-17 Astrazeneca Ab VERFAHREN ZUR HERSTELLUNG VON N,Ný-DISUBSTITUIERTEN OXABISPIDINEN
AR053901A1 (es) * 2005-06-20 2007-05-23 Astrazeneca Ab Formas fisicas de oxabispidinas n,n'- disustituidas
TW200734342A (en) * 2005-12-15 2007-09-16 Astrazeneca Ab New compounds for the treatment of cardiac arrhythmias
WO2007103970A2 (en) * 2006-03-07 2007-09-13 Endacea, Inc. Compositions and methods for treating respiratory disorders
EP3026044B8 (de) 2006-06-26 2018-12-19 Akebia Therapeutics, Inc. Prolylhydroxylasehemmer und verfahren zur verwendung
CA2837560C (en) 2011-06-06 2017-02-14 Akebia Therapeutics Inc. Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
NO2686520T3 (de) 2011-06-06 2018-03-17
CN114404414A (zh) 2013-06-13 2022-04-29 阿克比治疗有限公司 用于治疗贫血症的组合物和方法
TWI665190B (zh) 2013-11-15 2019-07-11 阿克比治療有限公司 {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式,其組合物及用途
US10150734B2 (en) 2015-01-23 2018-12-11 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
BR112017021097B1 (pt) 2015-04-01 2024-01-02 Akebia Therapeutics, Inc Formulação de dosagem oral e seu uso
TW202406895A (zh) 2018-05-09 2024-02-16 美商阿克比治療有限公司 用於製備2-[[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基]乙酸之方法
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3732094A1 (de) * 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
SE9704709D0 (sv) * 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
SE9902268D0 (sv) 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds

Also Published As

Publication number Publication date
ES2261721T3 (es) 2006-11-16
DK1389213T3 (da) 2006-07-10
EP1550663A1 (de) 2005-07-06
SK12572003A3 (sk) 2004-07-07
ATE323095T1 (de) 2006-04-15
IS6980A (is) 2003-10-08
HUP0303487A2 (hu) 2004-01-28
CA2443470A1 (en) 2002-10-24
MXPA03009206A (es) 2004-01-29
PT1389213E (pt) 2006-07-31
US7217708B2 (en) 2007-05-15
NO20034527D0 (no) 2003-10-09
DE60210598D1 (de) 2006-05-24
EP1389213B1 (de) 2006-04-12
TWI237025B (en) 2005-08-01
US20040143000A1 (en) 2004-07-22
AR035452A1 (es) 2004-05-26
SE0101327D0 (sv) 2001-04-12
ZA200307759B (en) 2005-01-03
RU2286993C2 (ru) 2006-11-10
HUP0303487A3 (en) 2005-04-28
BR0208829A (pt) 2004-03-09
EE200300504A (et) 2003-12-15
CZ20032760A3 (cs) 2004-01-14
HK1061026A1 (en) 2004-09-03
PL367179A1 (en) 2005-02-21
DE60210598T2 (de) 2007-02-08
NZ528560A (en) 2005-05-27
UA74629C2 (en) 2006-01-16
CN1514837A (zh) 2004-07-21
WO2002083688A1 (en) 2002-10-24
KR20030087078A (ko) 2003-11-12
JP2004525970A (ja) 2004-08-26
EP1389213A1 (de) 2004-02-18
IL158250A0 (en) 2004-05-12
RU2003129231A (ru) 2005-04-10
CN1269823C (zh) 2006-08-16

Similar Documents

Publication Publication Date Title
NO20041560L (no) 1,6-nafthyridinderivater som antidiabetiske midler
NO20042955L (no) Substituerte fenylaftalener som estrogene midler
DK1414803T3 (da) Pyrazolylcarboxanilider som fungicider
NO20026030L (no) Pyrrolo[2,3-d]pyramidin-forbindelser som immunosuppresive midler
NO20043022L (no) 5,6-diaryl-pyrazin-2-amid-derivater som CB1-antagonister
DE60216115D1 (de) BENZIMIDAZO 4,5-föISOCHINOLINON-DERIVATE
DK1379522T3 (da) Dihydro-benzo(b)(1,4)diazeping-2-on-derivater som MGLUR2-antagonister I
NO20034527L (no) 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser
ATE209899T1 (de) Feste, schnellzerfallende cetirizin- formulierungen
NO20022557D0 (no) 2,4-diaminopyrimidinforbindelser nyttige som immunosuppreserende midler
MXPA03009361A (es) Compuestos de urea utilies como agentes anti-inflamatorios.
DK1429607T3 (da) Delta-1-pyrroliner som pesticider
DK1339685T3 (da) Biphenylcarboxamider, der er egnede som lipidsænkende midler
DK1330458T3 (da) N-(1,2,4-triazoloazinyl)thiophensulfonamidforbindelser som herbicider
DK1263734T3 (da) 3-thiomethylpyrazoler som pesticider
NO20034529L (no) 3,7-diazabicyklo(3,3,1) - formuleringer som anti-arytmi- forbindelser
NO20034528D0 (no) 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser
DK1497256T3 (da) Substituerede 1,5-diaminopentan-3-ol-forbindelser
DK1380585T3 (da) Pyrazolopyridinon som mellemprodukt
SI1389213T1 (sl) 3,7-diazabiciklo(3.3.1)formulacije kot antiaritmicne spojine
DK1453820T3 (da) Substituerede 6H-dibenzo{c,h]vhromener som östrogene midler
TH85054EX (th) ???????????????????????????????????????????????
DE60224192D1 (de) Antihaemorrhagische, betain-enthaltende zusammenseuzungen
DK1448553T3 (da) N-Heterocyclylhydrazider som neurotrofe midler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application